Prediction of pharmacokinetic behaviour by combining in vivo and in vitro data in physiologically based pharmacokinetic (PBPK) model: Parameter estimation and sensitivity analysis

被引：0
|
作者：
Das, Debasish [1 ]
Dhurjati, Prasad [2 ]
Wangikar, Pramod P. [1 ,3 ]
机构：
[1] Department of Chemical Engineering, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
[2] Department of Chemical Engineering, University of Delaware, Newark, DE 19716, United States
[3] School of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
来源：
Journal of the Indian Institute of Science | 2008年 / 88卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：57 / 71
相关论文
共 50 条
  • [41] An ontology of Physiologically Based Pharmacokinetic Model (PBPK) for harmonization and automation of modeling framework (PBPKO)
    Kumar, V.
    Deepika, D.
    Kumar, S.
    Sharma, S.
    TOXICOLOGY LETTERS, 2024, 399 : S150 - S150
  • [42] Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
    Claassen, Karina
    Thelen, Kirstin
    Coboeken, Katrin
    Gaub, Thomas
    Lippert, Joerg
    Allegaert, Karel
    Willmann, Stefan
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (39) : 5688 - 5698
  • [43] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)
    Chiney, M. S.
    Polepally, A. R.
    Nader, A. M.
    Dufek, M. B.
    Klein, C. E.
    Ng, J. W.
    Shebley, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S59 - S59
  • [44] Prediction of dolutegravir pharmacokinetics and dose optimization in neonates via physiologically based pharmacokinetic (PBPK) modelling
    Bunglawala, Fazila
    Rajoli, Rajith K. R.
    Mirochnick, Mark
    Owen, Andrew
    Siccardi, Marco
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 640 - 647
  • [45] PARAMETER OPTIMIZATION IN PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR THE PREDICTION OF TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS WITH A NEW GLOBAL PARAMETER OPTIMIZATION METHOD
    Yoshida, K.
    Maeda, K.
    Kusuhara, H.
    Konagaya, A.
    Sugiyama, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S115 - S115
  • [46] Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study
    Yoon, Miyoung
    Kedderis, Gregory L.
    Yan, Grace Zhixia
    Clewell, Harvey J., III
    TOXICOLOGY, 2015, 332 : 52 - 66
  • [47] Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection
    Maruyama, Takumi
    Kimura, Toshimi
    Ebihara, Fumiya
    Kasai, Hidefumi
    Matsunaga, Nobuaki
    Hamada, Yukihiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (12) : 1152 - 1159
  • [48] PREDICTION OF CEREBRAL MORPHINE CONCENTRATION IN PEDIATRIC TRAUMATIC BRAIN INJURY (TBI) WITH THE RAT PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL
    Yamamoto, Y.
    Ketharanathan, N.
    de lange, E. C. M.
    Rohlwink, U.
    Wildschut, E. D.
    Mathot, R. A. A.
    Tibboel, D.
    Figaji, A. A.
    JOURNAL OF NEUROTRAUMA, 2016, 33 (03) : A38 - A38
  • [49] Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models
    Nestorov, IA
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (06): : 577 - 596
  • [50] Sensitivity Analysis of Pharmacokinetic and Pharmacodynamic Systems: I. A Structural Approach to Sensitivity Analysis of Physiologically Based Pharmacokinetic Models
    Ivan A. Nestorov
    Journal of Pharmacokinetics and Biopharmaceutics, 1999, 27 : 577 - 596
12345